Author
Listed:
- Sébastien Hannedouche
(Euroscreen S.A.)
- Juan Zhang
(Analytical Sciences, Novartis Institutes for BioMedical Research)
- Tangsheng Yi
(University of California San Francisco)
- Weijun Shen
(Genomics Institute of the Novartis Research Foundation
The Scripps Research Institute)
- Deborah Nguyen
(Genomics Institute of the Novartis Research Foundation)
- João P. Pereira
(University of California San Francisco)
- Danilo Guerini
(Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research)
- Birgit U. Baumgarten
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Silvio Roggo
(Global Discovery Chemistry, Novartis Institutes for BioMedical Research)
- Ben Wen
(Genomics Institute of the Novartis Research Foundation)
- Richard Knochenmuss
(Analytical Sciences, Novartis Institutes for BioMedical Research)
- Sophie Noël
(Euroscreen S.A.)
- Francois Gessier
(Global Discovery Chemistry, Novartis Institutes for BioMedical Research)
- Lisa M. Kelly
(University of California San Francisco)
- Mirka Vanek
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Stephane Laurent
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Inga Preuss
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Charlotte Miault
(Global Discovery Chemistry, Novartis Institutes for BioMedical Research)
- Isabelle Christen
(Analytical Sciences, Novartis Institutes for BioMedical Research)
- Ratna Karuna
(Analytical Sciences, Novartis Institutes for BioMedical Research)
- Wei Li
(Genomics Institute of the Novartis Research Foundation)
- Dong-In Koo
(The Scripps Research Institute)
- Thomas Suply
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Christian Schmedt
(Genomics Institute of the Novartis Research Foundation)
- Eric C. Peters
(Genomics Institute of the Novartis Research Foundation)
- Rocco Falchetto
(Analytical Sciences, Novartis Institutes for BioMedical Research)
- Andreas Katopodis
(Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research)
- Carsten Spanka
(Global Discovery Chemistry, Novartis Institutes for BioMedical Research)
- Marie-Odile Roy
(Euroscreen S.A.)
- Michel Detheux
(Euroscreen S.A.)
- Yu Alice Chen
(Genomics Institute of the Novartis Research Foundation)
- Peter G. Schultz
(Genomics Institute of the Novartis Research Foundation)
- Charles Y. Cho
(Genomics Institute of the Novartis Research Foundation)
- Klaus Seuwen
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
- Jason G. Cyster
(University of California San Francisco)
- Andreas W. Sailer
(Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research)
Abstract
EBI2 receptors revealed as oxysterols The EBI2 receptor (Epstein–Barr virus-induced gene 2, also known as GPR183) was recently shown to be linked to autoimmune disease, and is a critical regulator of the humoral immune response. It is a G-protein-coupled receptor, and its natural ligand has been unknown. Two groups now bring an end to the 'orphan' status of this receptor with identification of specific oxysterols as its natural ligands. The most potent ligand and activator is 7a,25-dihydroxycholesterol, and the EBI2–oxysterol signalling pathway has an important role in the adaptive immune response.
Suggested Citation
Sébastien Hannedouche & Juan Zhang & Tangsheng Yi & Weijun Shen & Deborah Nguyen & João P. Pereira & Danilo Guerini & Birgit U. Baumgarten & Silvio Roggo & Ben Wen & Richard Knochenmuss & Sophie Noël , 2011.
"Oxysterols direct immune cell migration via EBI2,"
Nature, Nature, vol. 475(7357), pages 524-527, July.
Handle:
RePEc:nat:nature:v:475:y:2011:i:7357:d:10.1038_nature10280
DOI: 10.1038/nature10280
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:475:y:2011:i:7357:d:10.1038_nature10280. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.